GT Medical Technologies Raises $100 Million Series E to Expand GammaTile Brain Tumor Treatment Platform

GT Medical Technologies has closed an oversubscribed $100 million Series E financing, securing capital to accelerate commercialization of its GammaTile... Read More

The post GT Medical Technologies Raises $100 Million Series E to Expand GammaTile Brain Tumor Treatment Platform appeared first on citybiz.